Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cara Therapeutics, Inc.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has ESRD and has been on hemodialysis 3 times per week for at least 3 months;
Not currently taking opioid medication;
If female, is not pregnant or nursing during any period of the study.
You may not be if
Has a concomitant disease or a history of any condition that, in the opinion of the Investigator, could pose undue risk to the patient, impede completion of the study procedures, or would compromise the validity of the study measurements; Past or present diseases, which as judged by the Investigator, may affect the outcome of this study.
Clareo Health | CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients
